vimarsana.com
Home
Live Updates
Study identifies PI3K-beta as key target in overcoming chemo
Study identifies PI3K-beta as key target in overcoming chemo
Study identifies PI3K-beta as key target in overcoming chemotherapy resistance in glioblastoma
For many patients with a deadly type of brain cancer called glioblastoma, chemotherapy resistance is a big problem.
Related Keywords
China ,
Virginia ,
United States ,
Zhi Sheng ,
Chongqing ,
Philadelphia ,
Pennsylvania ,
Chinese ,
Kevin Pridham ,
Patrick Beck ,
Las Vegas ,
Kasen Hutchings ,
Virginia Tech Carilion School Of Medicine ,
National Institutes Of Health ,
Fralin Biomedical Research Institute ,
Cancer Genome Atlas Research Network ,
Virginia Tech ,
Fralin Biomedical Research ,
Virginia Tech Carilion School ,
Dependency Map ,
Genotype Tissue Expression ,
Chinese Glioma Genome ,
National Institutes ,